Beclomethasone 倍氯米松溶液
CAS 4419-39-0 MFCD00135614
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- {SNA} Approved Therapeutics/Drug Candidates, B, Bioactive Small Molecules, Cell Signaling and Neuroscience, GlaxoSmithKline, Immune Cell Signaling and Blood, Immune System Regulation, Immunomodulators and Antibiotics, 细胞生物学
- {SNA} Approved Therapeutics/Drug Candidates, B, GlaxoSmithKline, Immune Cell Signaling and Blood, Immune System Regulation, Immunomodulators and Antibiotics, 生物活性小分子, 细胞信号转导和神经科学, 细胞生物学
- {SNA} Approved Therapeutics/Drug Candidates, B, Bioactive Small Molecules, Cell Biology, Cell Signaling and Neuroscience, GlaxoSmithKline, Immune Cell Signal
产品应用
- 校准仪器和装置;评价方法;工作标准;质量保证/质量控制
相关文献及参考
- Brogden, R.N., et al.: Drugs, 28, 99 (1984),
- Malfitan, V.A., et al.: Clin. Ther., 4, 472 (1982),
- Rao, M., et al.: J. Asthma, 19, 21 (1982),
- Small, P., et al.: Ann. Allergy, 49, 127 (1982),
- [1]. He S, et al. Neutrophil-mediated experimental metastasis is enhanced by VEGFR inhibition in a zebrafish xenograft model. J Pathol. 2012 Aug;227(4):431-45.
安全信息
GHS Symbol
- S24/25 Avoid contact with skin and eyes 避免皮肤和眼睛接触;
- P262 Do not get in eyes, on skin, or on clothing. 不要接触眼睛,皮肤或衣服。
其他信息
- 方法一:由地塞米松制得。
- 用途一:制取倍氯米松二丙酸酯。
- Sigma Aldrich:4419-39-0(sigmaaldrich)
- MOL 文件:4419-39-0.mol
- 上游原料:地塞米松